China Biologic Products Holdings, Inc. CBPO
— —
Day range unavailable
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 102.78
- Target (low)
- 77.00
- Target (mean)
- 102.78
- Target (high)
- 119.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
- Strong buy3
- Buy5
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 4
- 2 months ago 4
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 557.93M | +6.4% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 609.55M | +9.3% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 11, 2019 | Jefferies | Downgrade | Hold | Underperform |
| Nov 5, 2018 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| May 14, 2018 | Jefferies | Downgrade | Buy | Hold |
| Aug 8, 2016 | Jefferies | Maintained | — | Buy |
| Mar 1, 2016 | Credit Suisse | Downgrade | Outperform | Neutral |
| Feb 29, 2016 | Jefferies | Maintained | — | Buy |
| Aug 7, 2015 | Jefferies | Maintained | — | Buy |
| Jul 9, 2015 | Bank of America | Initiated | — | Buy |
| Nov 6, 2014 | Jefferies | Maintained | — | Buy |
| Sep 3, 2014 | Aegis Capital | Maintained | — | Buy |
| Jul 24, 2014 | Jefferies | Maintained | — | Buy |
| May 22, 2014 | Jefferies | Initiated | — | Buy |
| Mar 14, 2014 | Oppenheimer | Initiated | — | Outperform |
| Nov 6, 2013 | Aegis Capital | Downgrade | Buy | Hold |
| Jan 11, 2013 | Aegis Capital | Maintained | — | Buy |
| Dec 12, 2012 | Aegis Capital | Initiated | — | Buy |